Post-traumatic stress disorder

PulteGroup Breaks Ground on New Mortgage-Free Home for U.S. Air Force Veteran in Michigan

Retrieved on: 
Thursday, June 1, 2023
Philanthropy, Defense, Residential Building & Real Estate, Other Philanthropy, Construction & Property, Veterans, Air Medal, Patriot Guard Riders, Caregiver, Built, United States Air Force, Rolling, Multimedia, Veteran, Military personnel, PulteGroup, Warrior, Obey, Post-traumatic stress disorder, Strong Mayors, Building Homes Act, Washtenaw County, Michigan, Pulte, Family, News, Life insurance, Airline, Nursing

The Obey family recently took part in a groundbreaking ceremony for their new, mortgage-free home at Pulte Homes’ Thornton Farms West community in Dexter, Michigan.

Key Points: 
  • The Obey family recently took part in a groundbreaking ceremony for their new, mortgage-free home at Pulte Homes’ Thornton Farms West community in Dexter, Michigan.
  • “It is truly an honor and privilege to be able to build this home for Master Sergeant Obey and his family,” said Kevin Christofferson, president of PulteGroup’s Michigan division.
  • Master Sergeant Obey and his crew often received enemy fire during takeoffs and landings into dangerous combat zones.
  • He has also received several other medals, awards and ribbons for his valor and service.

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application.

Retrieved on: 
Friday, May 26, 2023
MDAI, Therapy, MEAI, PTSD, PCT, MDE, Literature, Patent, Post-traumatic stress disorder, Patient, USE, MBDB, Empathy, Terran, SALTS, MDMA, MDEA, Pharmaceutical industry

MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.

Key Points: 
  • MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.
  • Historically, MDMA has only been developed as a single salt and the crystal structures of its enantiomers had not been characterized.
  • As previously reported, Terran found that the S enantiomer of MDEA had significant advantages over the (R)-MDEA in preclinical models.
  • Terran is also developing the S enantiomer of MBDB which was shown to have significant advantages over (R)-MBDB in preclinical models.

COHEN VETERANS BIOSCIENCE AND 22 JUMPS ANNOUNCE PARACHUTING WITH PURPOSE: RECOGNIZING THE EPIDEMIC OF VETERANS SUICIDE AS A RESULT OF TRAUMATIC BRAIN INJURY (TBI) AND PTSD

Retrieved on: 
Tuesday, May 23, 2023
Therapy, Suicide, Perrine Bridge, Orpheum, Traumatic brain injury, Physician, Hope, Research, Brain, TBI, Doctor of Philosophy, Organization, CVB, Stigma, Orpheum Theatre (Memphis), MD, Post-traumatic stress disorder, Community Coordinated Modeling Center, Diagnosis, FDA, Mental health, PTSD, Nightclub, Nursing, Medical device, Female, Veteran

NEW YORK, May 23, 2023 /PRNewswire/ -- On Saturday, May 27, 2023, four Veteran jumpers will leap from the Perrine Bridge in Twin Falls, Idaho 22 times each in a single day — 22 symbolic of the estimated 22 servicemembers and Veterans who take their lives each day. This year's jumpers include:

Key Points: 
  • Proceeds from ticket sales will help develop new solutions for TBI for service members and Veterans.
  • 22 Jumps aims to bring new hope to individuals and families affected by TBI and suicide.
  • Cohen Veterans Bioscience is a non-profit biomedical research organization leading a new approach to research, diagnosis, and treatment of PTSD and TBI.
  • The TBI Action Alliance is a new Community Coordination model to accelerate a first generation of diagnostics and treatments for Traumatic Brain Injury.

This Week in Policy & Public Interest News: 13 Stories You Need to See

Retrieved on: 
Friday, May 19, 2023
Acute stress disorder, Humanity, Policy, Habitat for Humanity, PR Newswire, Housing, PTSI, Crayola, Post-traumatic stress disorder, PTSD, Kubota

NEW YORK, May 19, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the policy and public interest industries stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

Key Points: 
  • A roundup of the week's most newsworthy policy and public interest press releases from PR Newswire, including Habitat for Humanity's new campaign and the launch of a new ethics accelerator.
  • NEW YORK, May 19, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire.
  • To help journalists covering the policy and public interest industries stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.
  • The list below includes the headline (with a link to the full text) and an excerpt from each story.

Think you might be dating a 'vulnerable narcissist'? Look out for these red flags

Retrieved on: 
Wednesday, May 17, 2023
People, Communication, Violence, Neuroticism, RESPECT, Domestic violence, Personality disorder, Research, Attention, Affection, Female, Ghosting, Narcissism, Intention, Walking, Mask, Post-traumatic stress disorder, Risk, Love, Misrepresentation, Personality, Family, Psychopathy, Safety, Online shopping, Shipbuilding, Retail, Tutoring, Microscope, Medical device, Nursing, Machiavellianism

Single people are increasingly turning online to find love, with more than 300 million people around the world trying their luck on dating apps.

Key Points: 
  • Single people are increasingly turning online to find love, with more than 300 million people around the world trying their luck on dating apps.
  • But for others, stories of online dating have very different endings.

The dark side of online dating

    • But online dating isn’t without risk.
    • Antisocial dating behaviours are common online, such as ghosting and breadcrumbing (when someone gives you crumbs of attention to keep you interested, with no intention of progressing the relationship).
    • One study found up to 81% of online dating users had engaged in some form of it.

Behind the mask

    • Narcissism in a broad sense can be conceptualised as a personality trait that falls on a continuum.
    • Those at the extreme end are characterised by entitlement, superiority, and a strong need for attention, admiration and approval.
    • Vulnerable narcissism is characterised by high emotional sensitivity and a defensive, insecure grandiosity that masks feelings of incompetence and inadequacy.

Here’s what we found

    • That is, those with higher scores for vulnerable narcissism presented more inauthentically.
    • Participants who had ghosted or breadcrumbed someone also had higher scores for vulnerable narcissism.
    • However, it should be noted these effects were small, and not everyone who ghosts is likely to be a vulnerable narcissist.

Might I be dating a vulnerable narcissist?


    Vulnerable narcissists can be difficult to identify in the early stages of dating because the persona they present isn’t their authentic self. Over time, however, the mask usually comes off. If you’re wondering whether you’re dating a vulnerable narcissist, look out for these red flags waving in sync.

I think I’m dating a vulnerable narcissist!

    • Vulnerable narcissists are prone to engaging in emotionally abusive behaviours.
    • If you suspect you’re dating one then you may be experiencing domestic violence, or be at significant risk of it if the relationship continues.
    • If you have concerns, it’s important to seek support from your family doctor, a psychologist, or a domestic violence support service.

Erase PTSD Now Kicks Off Campaign to Change the Term PTSD (Post Traumatic Stress Disorder) to PTSI (Post-Traumatic Stress Injury)

Retrieved on: 
Monday, May 15, 2023
Survivor, American Psychiatric Association, Plague, Sympathetic nervous system, APA, Diagnosis, DSM-IV codes, Brain, Research, PTSI, Mental, Movement, Pain, Organization, Disorder, Post-traumatic stress disorder, Patient, Acute stress disorder, National Council, Anesthesiology, Diagnostic and Statistical Manual of Mental Disorders, Trauma, Chronic pain, PTSD, Migraine, Meat

Therefore, Erase PTSD Now is petitioning for a name change and kicking off a national campaign for PTSD to now be referred to as PTSI.

Key Points: 
  • Therefore, Erase PTSD Now is petitioning for a name change and kicking off a national campaign for PTSD to now be referred to as PTSI.
  • "At Erase PTSD Now, our goal is to restore individuals, as well as affected families and communities, to a pre-trauma state.
  • We believe that changing the name from PTSD to PTSI is an important step in achieving that goal," explains Coleen LaCosta, Executive Director of Erase PTSD Now.
  • Erase PTSD Now is calling on individuals, organizations, and communities to join the movement and support efforts to change PTSD to PTSI: an Injury that is treatable.

Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments

Retrieved on: 
Friday, May 12, 2023
Science, Other Science, Biotechnology, Pharmaceutical, Surgery, Health, Infectious Diseases, Other Health, Insurance, Rat, CRADA, National Center for Advancing Translational Sciences, Bangladesh Technical Education Board, Chemistry, Investigational New Drug, Acquisition, U.S. Department of Defense Strategy for Operating in Cyberspace, Pain management, Federation, Nanotechnology, FINANCIAL, Policy, Innovation, Research, Dog, MET, FDA, IND, NIH, Technology transfer, Safety, Intellectual property, Harvard University, Therapy, Pain, Epilepsy, Central nervous system, CMC, NCATS, CNS, Molecular biology, Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., Post-traumatic stress disorder, Physician, OTC, Chronic pain, Pharmaceutical industry, Cryptocurrency, Medical device, Biochemistry

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced its financial results for the three months ended March 31, 2023, and other recent developments.

Key Points: 
  • Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced its financial results for the three months ended March 31, 2023, and other recent developments.
  • We remain on track to file the Investigational New Drug (IND) application by the second quarter of 2024.
  • On April 5, 2023, Virpax announced the successful completion of dose ranging studies for rats and dogs in its Envelta development program.
  • Cash used in operations was approximately $2.0 million for the first quarter of 2023 compared to $6.0 million for the three months ended March 31, 2022.

Brain-altering fungi could lead the next frontier in mental health care

Retrieved on: 
Thursday, May 11, 2023
Psilocybin, Parasitism, Communication, Hallucination, Human, Travel, Depression, Awareness, Lysergic acid diethylamide, Anxiety, Brain, Research, LSD, Medicine, Fungus, Government, Thought, Aztecs, DSM-IV codes, The Last of Us, Post-traumatic stress disorder, Patient, Map, Nervous system, Dysthymia, Serotonin, Health, Environment, Mental health, Spore, PTSD, Safety, Truffle, Pharmaceutical industry, Medical imaging, Cordyceps

The series is set in a post-apocalyptic world where parasitic fungi take control of the human brain, turning people into killer zombies.

Key Points: 
  • The series is set in a post-apocalyptic world where parasitic fungi take control of the human brain, turning people into killer zombies.
  • Parasitic or “zombie” fungi that alter the mind and behaviour of their hosts do exist.
  • When spores are ingested by insects, they germinate and grow, secreting molecules that travel to the host’s brain and interfere with its function.

Fungi that alter our minds

    • In the case of humans, some fungi which produce small molecules, or metabolites, that alter our minds – and recent research shows these have therapeutic potential.
    • Humans have known about the hallucinogenic properties of fungi for centuries.
    • The Aztecs even gave magic mushrooms to people who were dying to promote a peaceful transition to the afterlife.
    • But recently, there’s been an explosion of interest in fungal metabolites, specifically because of their neurological benefits and potential in treating mental health conditions.
    • Additional studies demonstrate the positive effect of fungal metabolites in treating a range of conditions – including anxiety, depression and alcohol addiction.

No miracle cure

    • That said, psychedelics should not be considered a miracle cure as there is still a lot we don’t know.
    • Furthermore, most studies on psychedelics are still preliminary as they use a limited number of participants.
    • Furthermore, psychedelics are powerful and unpredictable – and the safety and long-term effects of such treatment is unknown.

Dr. Newton Howard Joins Futures Recovery Healthcare Hero's Ascent Advisory Board

Retrieved on: 
Thursday, May 11, 2023
Newton, Substance Abuse, Depression, Report, University, Post-traumatic stress disorder, KIWI, Suicide, Anxiety, Ascent, Hero, Curriculum, Clinical trial, DSM-IV codes, Hero's, Substance Abuse and Mental Health Services Administration, Hope, PTSD, Nuffield Department of Population Health, Research, Brain, Medicine, Psychedelic treatments for trauma-related disorders, Privacy, Veteran, Bangladesh Technical Education Board, Military personnel, Surgery, Death, Alzheimer's disease, Professor, Parkinson's disease, Kinetic, Neurology, Knowledge, Mental health service, IED, Trauma, Mental health, John Radcliffe Hospital, Nursing, Medical device

JUPITER, Fla., May 11, 2023 /PRNewswire/ -- Futures Recovery Healthcare is privileged to welcome Dr. Newton Howard to its Hero's Ascent Advisory Board which helps meet the intense behavioral healthcare needs of first responders, active military members, and veterans.

Key Points: 
  • JUPITER, Fla., May 11, 2023 /PRNewswire/ -- Futures Recovery Healthcare is privileged to welcome Dr. Newton Howard to its Hero's Ascent Advisory Board which helps meet the intense behavioral healthcare needs of first responders, active military members, and veterans.
  • Futures Recovery Healthcare Hero's Ascent makes specialized mental health, substance use disorder, and trauma treatment services accessible to first responders, military personnel, veterans, and their family members.
  • Futures Recovery Healthcare assembled the Hero's Ascent Advisory Board to make its Hero's Ascent offering as effective and relevant as possible.
  • As a Hero's Ascent Advisory Board member, Dr. Howard's work and relatability will profoundly impact first responders and families.

Terran Biosciences announces publication of four PCT patent applications covering breakthroughs in novel empathogens, including improved versions of methylone, ethylone, MDEA, MDAI, and MBDB

Retrieved on: 
Thursday, May 11, 2023
MDMC, REMS, MDAI, Depression, Therapy, MDEA, Mitigation, Methylone, Anxiety, Therapeutic index, Pathology, Pharmacokinetics, PCT, MDE, DSM-IV codes, Literature, OF, Patent, Patient, Post-traumatic stress disorder, USE, MBDB, Empathy, Salt, SALTS, MDMA, Safety, Pharmaceutical industry, Vaccine, Terran, PTSD

The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.

Key Points: 
  • The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.
  • Terran believes that therapeutic options for patients should be equally diverse, with unique psychedelics and empathogens tailored to specific patient needs.
  • Terran completed what is believed to be the first comprehensive salt and polymorph screen performed to date on this compound.
  • Terran completed additional improvements including the synthesis of deuterated forms of racemic methylone, R-methylone, and S-methylone with improved pharmacokinetics.